English
Specials
Upgrade

Moneycontrol

Budget 2023Budget 2023
Get App Open
In App
Open App

LIVE COVERAGE AND VIDEO PARTNERS

Lenovo Tech Today India Prestige Group Acer India
you are here:
Success
Alert
Please select a Day.
Info
Open Trading Account

Ranbaxy Laboratories Ltd.

Sector: Pharmaceuticals
Add to
Stock not traded in NSE.
Stock not traded in BSE.
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
MC Essentials
50% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Stock not eligible for rating

Financials
    Ownerships
      Industry Comparison
        Others
          Powered by Powered by Trendlyne
          Open 814.70
          Previous Close 859.80
          Volume 5,415,702.00
          Value (Lacs) 46,564.21
          i  VWAP 847.00
          Beta
          High 869.70
          Low 809.45
          UC Limit 36.75
          LC Limit 33.25
          52 Week High 869.70
          52 Week Low 371.50
          TTM EPS See historical trend -19.07
          TTM PE See historical trend --
          P/B See historical trend 11.08
          Face Value 5.00
          Mkt Cap (Rs. Cr.) 36,599
          Dividend Yield 0.00
          20D Avg Volume 0
          20D Avg Delivery(%) --
          Sector PE 31.17
          Book Value Per Share 77.61

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          MC Insights

          Stock not eligible for rating

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison

          Shareholding Pattern
          Powered by Powered by Trendlyne

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Historical Prices
          Volume Analysis

          Forum

          Community Sentiments

          Data not Available

          What's your call on today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          16 Sep, 2013

          PACE STOCK BROKING SERVICES PRIVATE LIMITED

          Qty 2123826 Price 333.62 % Traded 0.00
          16 Sep, 2013

          PACE STOCK BROKING SERVICES PRIVATE LIMITED

          Qty 2014675 Price 333.92 % Traded 0.00

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Powered by Powered by Trendlyne

          Insider Transaction Summary

          No Data For Insider Transaction Summary.

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          No Data For Substantial Acquisition of Shares & Takeovers.

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Corporate Action

          • No Data For Announcement.
          + See More
          Date Agenda
          + See More
          Ex-Date Type Dividend (Rs)
          + See More
          Announcement Date Ex-Bonus Ratio
          + See More
          Ex-Split Old FV New FV
          + See More
          Ex-Right Ratio Premium
          + See More
          Date Agenda
          + See More

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary

          No Data For Summary.

          Trend
          Insights

          No Data For Institutional Holder Analysis.

          • No Data For Insight.

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Ranbaxy Labs 859.90 - 36,602.80 - 33.34 0.00 - -879 6,864 5.46
          Suyog Gurbaxani 49.45 - 122.94 - 12.46 -70.22 6.34 -6 8 6.88
          Lucent Ind. 35.85 - 53.78 - 3.69 -0.41 - 0 0 0.26
          Gateway Dist-RE 14.00 - 22.53 - - -0.41 - 0 0 0.26
          Net Pix 35.00 - 11.20 - 1.90 -4.06 9.38 0 0 0.09
          + See More

          About the Company

          Ranbaxy Laboratories Ltd. is pharmaceutical company. It develops, manufactures and markets generic, branded generic, over-the-counter products, anti-retrovirals, active pharmaceutical ingredients and intermediates. Its products include simvastatin, amoxyclav potassium, isotretinion, ciprofloxacin, isotretinon, cephalexin, ketorolac tromethamine, cefaclor, clarithromycin and cefuroxime axetil. The company was founded in 1961 and is based in Gurgaon, Haryana. Ranbaxy Laboratories Ltd. operates as a subsidiary of Daiichi Sankyo Company Ltd.
          {"success":1,"data":{"address":{"address1":"A-41, Industrial Area,","address2":"Phase-VIII-A,,Sahibzada Ajit Singh Nagar","city":"Mohali","state":"Punjab","pincode":"160071","telephone1":"0172-6678666","telephone2":"","fax1":"0172-5013376","fax2":"","email":"secretarial@ranbaxy.com","web":"http:\/\/www.ranbaxy.com"},"management":[{"name":"Tsutomu Une","designation":"Chairman"},{"name":"Arun Sawhney","designation":"Managing Director & CEO"},{"name":"Akihiro Watanabe","designation":"Director"},{"name":"Anthony H Wild","designation":"Director"},{"name":"Kazunori Hirokawa","designation":"Director"}],"registrars":{"name":"Alankit Assignment Ltd.","address1":"No.2E\/21, Alankit House,","address2":"Jhandewalan Extension","address3":"","address4":"","telephone":"011-23541234, 42541234","fax":"011-42541201, 51540064","email":"info@alankit.com","internet":"http:\/\/www.alankit.com","city":"New Delhi","state":"Delhi","pincode":"110055"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"}],"details":{"bseId":"500359","nseId":"RANBAXY","series":"","isinid":"INE015A01028"}}}

          • Registered Office

          • Registrars

            • Address

              No.2E/21, Alankit House,,Jhandewalan Extension

            • City

              New Delhi 110055

            • State

              Delhi

            • Tel. No.

              011-23541234, 42541234

            • Fax No.

              011-42541201, 51540064

            • Email

              info@alankit.com

            • Internet

              http://www.alankit.com

          • Management

            • Tsutomu Une

              Chairman

            • Arun Sawhney

              Managing Director & CEO

            • Akihiro Watanabe

              Director

            • Anthony H Wild

              Director

            • Kazunori Hirokawa

              Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

          • Details

            • BSE:

              500359

            • NSE:

              RANBAXY

            • Series

            • ISIN

              INE015A01028

          Go to Top

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>